Phosphorylation and functions of inhibitor-2 family of proteins

被引:44
|
作者
Li, Mingguang
Satinover, David L.
Brautigan, David L.
机构
[1] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22903 USA
[2] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22903 USA
关键词
D O I
10.1021/bi602369m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatase-1 (PP1) is an essential protein Ser/Thr phosphatase that is extraordinarily conserved from yeast to human, and Inhibitor-2 (I-2) is the most ancient of the heat-stable proteins specific for PP1. We identified novel I-2 homologues in Caenorhabditis elegans (Ce) and Xenopus laevis (Xe) and compared them to the I-2 proteins from Homo sapiens (Hs), Saccharomyces cerevisiae (GLC8), and Drosophila melanogaster (Dm). The Ce I-2 and Dm I-2 showed the highest potency inhibition of rabbit PP1 with IC50 near 5 nM compared to Hs I-2 and Xe I-2 with IC50 between 10 and 50 nM and GLC8 with > 100-fold lower activity. Inhibition of PP1 bound to Nek2 kinase activated the kinase to phosphorylate a C-Nap1 domain substrate. All the species of I-2 except GLC8 activated the Nek2::PP1 to the same extent as microcystin-LR. Only Hs I-2 and Xe I-2, not the I-2 proteins more divergent in sequence, directly activated human Aurora-A kinase. Various species of I-2 have a common PxTP phosphorylation site that showed a wide range of reactivity with GSK3, ERK, or CDC2/cyclinB1 kinases. The Suc1 subunit of CDC2/cyclinB1 enhanced reactivity with I-2, consistent with this being a site of mitotic phosphorylation. The results show species specificity among the I-2 family within the context of conserved PP1 inhibitory activity and variable phosphorylation by Pro-directed kinases.
引用
收藏
页码:2380 / 2389
页数:10
相关论文
共 50 条
  • [21] Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes
    Swartz, JM
    Byström, J
    Dyer, KD
    Nitto, T
    Wynn, TA
    Rosenberg, HF
    JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (04) : 812 - 819
  • [22] Phosphorylation of secreted proteins by a new family of kinases
    Tagliabracci, Vincent S.
    Wiley, Sandra
    Dixon, Jack
    FASEB JOURNAL, 2016, 30
  • [23] PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN PATIENTS WITH MONOCYTIC LEUKEMIA
    SCHERRER, A
    KRUITHOF, EKO
    GROB, JP
    LEUKEMIA, 1991, 5 (06) : 479 - 486
  • [24] INVIVO ACTIONS OF PROTEIN PHOSPHATASE INHIBITOR-2 IN XENOPUS OOCYTES
    FOULKES, JG
    MALLER, JL
    FEBS LETTERS, 1982, 150 (01) : 155 - 160
  • [25] Tissue factor pathway inhibitor-2 is critical in zebrafish cardiogenesis
    Zhang, Yanli
    Wang, Huijun
    Wen, Danping
    Zhang, Jin
    Zheng, Fengyun
    Jiang, Nan
    Ma, Duan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (03) : 827 - 833
  • [26] Overexpression of protein phosphatase inhibitor-2 in an adenoviral expression system
    Balzer, F
    Aleth, S
    Hafer, L
    Schmitz, W
    Neumann, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R95 - R95
  • [27] Structure, function and biology of tissue factor pathway inhibitor-2
    Chand, HS
    Foster, DC
    Kisiel, W
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (06) : 1122 - 1130
  • [28] Structural basis for regulation of protein phosphatase 1 by inhibitor-2
    Hurley, Thomas D.
    Yang, Jie
    Zhang, Lili
    Goodwin, Kristie D.
    Zou, Qin
    Cortese, Marc
    Dunker, A. Keith
    DePaoli-Roach, Anna A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (39) : 28874 - 28883
  • [30] PLASMINOGEN-ACTIVATOR INHIBITOR-2 - BIOCHEMICAL AND CLINICAL ASPECTS
    KRUITHOF, EKO
    SCHLEUNING, WD
    BACHMANN, F
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 534 - 534